Literature DB >> 17481579

Production of mouse monoclonal antibody with galactose-extended sugar chain by suspension cultured tobacco BY2 cells expressing human beta(1,4)-galactosyltransferase.

Kazuhito Fujiyama1, Aiko Furukawa, Atsuya Katsura, Ryo Misaki, Takeshi Omasa, Tatsuji Seki.   

Abstract

Previously, we developed a transgenic tobacco BY2 cell line (GT6) in which glycosylation was modified by expressing human beta(1,4)-galactosyltransferase (betaGalT). In this study, we produced a mouse monoclonal antibody in GT6 cells, and determined the sugar chain structures of plant-produced antibodies. Galactose-extended N-linked glycans comprised 16.7%, and high-mannose-type and complex-type glycans comprised 38.5% and 35.0% of the total number of glycans, respectively. N-linked glycans with the plant-specific sugars beta(1,2)-xylose and alpha(1,3)-fucose comprised 9.8%. The introduction of human betaGalT into suspension cultured tobacco cells resulted in the production of recombinant proteins with galactose-extended glycans and decreased contents of beta(1,2)-xylose and alpha(1,3)-fucose.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17481579     DOI: 10.1016/j.bbrc.2007.04.054

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Glycan structure and serum half-life of recombinant CTLA4Ig, an immunosuppressive agent, expressed in suspension-cultured rice cells with coexpression of human β1,4-galactosyltransferase and human CTLA4Ig.

Authors:  Seung Hoon Kang; Hahn Sun Jung; Song Jae Lee; Cheon Ik Park; Sang Min Lim; Heajin Park; Byung Sun Kim; Kwang Heum Na; Gyeong Jin Han; Jae Woo Bae; Hyun Joo Park; Keuk Chan Bang; Byung Tae Park; Hye Seong Hwang; In-Soo Jung; Jae Il Kim; Doo Byung Oh; Dong Il Kim; Hirokazu Yagi; Koichi Kato; Dae Kyong Kim; Ha Hyung Kim
Journal:  Glycoconj J       Date:  2015-05-14       Impact factor: 2.916

2.  Glyco-Engineering of Plant-Based Expression Systems.

Authors:  Rainer Fischer; Tanja Holland; Markus Sack; Stefan Schillberg; Eva Stoger; Richard M Twyman; Johannes F Buyel
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

3.  N-Glycosylation of an IgG antibody secreted by Nicotiana tabacum BY-2 cells can be modulated through co-expression of human β-1,4-galactosyltransferase.

Authors:  Catherine Navarre; Nicolas Smargiasso; Laurent Duvivier; Joseph Nader; Johann Far; Edwin De Pauw; Marc Boutry
Journal:  Transgenic Res       Date:  2017-03-22       Impact factor: 2.788

Review 4.  Humanizing glycosylation pathways in eukaryotic expression systems.

Authors:  Amjad Hayat Khan; Hadi Bayat; Masoumeh Rajabibazl; Suriana Sabri; Azam Rahimpour
Journal:  World J Microbiol Biotechnol       Date:  2016-11-11       Impact factor: 3.312

5.  Production of different glycosylation variants of the tumour-targeting mAb H10 in Nicotiana benthamiana: influence on expression yield and antibody degradation.

Authors:  Raffaele Lombardi; Marcello Donini; Maria Elena Villani; Patrizia Brunetti; Kazuhito Fujiyama; Hiroyuki Kajiura; Matthew Paul; Julian K-C Ma; Eugenio Benvenuto
Journal:  Transgenic Res       Date:  2012-01-12       Impact factor: 2.788

6.  Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile.

Authors:  Richard Strasser; Alexandra Castilho; Johannes Stadlmann; Renate Kunert; Heribert Quendler; Pia Gattinger; Jakub Jez; Thomas Rademacher; Friedrich Altmann; Lukas Mach; Herta Steinkellner
Journal:  J Biol Chem       Date:  2009-05-28       Impact factor: 5.157

7.  Unexpected Arabinosylation after Humanization of Plant Protein N-Glycosylation.

Authors:  Lennard L Bohlender; Juliana Parsons; Sebastian N W Hoernstein; Nina Bangert; Fernando Rodríguez-Jahnke; Ralf Reski; Eva L Decker
Journal:  Front Bioeng Biotechnol       Date:  2022-02-18

Review 8.  Plant-based strategies aimed at expressing HIV antigens and neutralizing antibodies at high levels. Nef as a case study.

Authors:  Carla Marusic; Alessandro Vitale; Emanuela Pedrazzini; Marcello Donini; Lorenzo Frigerio; Ralph Bock; Philip J Dix; Matthew S McCabe; Michele Bellucci; Eugenio Benvenuto
Journal:  Transgenic Res       Date:  2009-01-25       Impact factor: 2.788

9.  Development of patatin knockdown potato tubers using RNA interference (RNAi) technology, for the production of human-therapeutic glycoproteins.

Authors:  Yoon-Sik Kim; Yong-Hwa Lee; Hyun-Soon Kim; Mi-Sun Kim; Kyu-Woong Hahn; Jeong-Heon Ko; Hyouk Joung; Jae-Heung Jeon
Journal:  BMC Biotechnol       Date:  2008-04-03       Impact factor: 2.563

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.